About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

Not Yet RecruitingNANCT06760650

Fluorescein Angiography in Patients With Diabetes and Chronic Kidney Disease

Our study hypothesizes that fluorescein exposure in diabetic patients with advanced chronic kidney disease results in deterioration of kidney function. It will therefore aim to evaluate the incidence ...

Lead sponsor: Saint-Joseph University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Contacts

Mabel AOUN, M.D., M.P.H.

CONTACT

+9613351588 aounmabel@yahoo.fr

Anthony NOHRA, Medical Student

CONTACT

anthony.nohra1@net.usj.edu.lb

Sponsors

Lead Sponsor

Saint-Joseph University

This study will assess the change in serum creatinine in patients with diabetes and advanced chronic kidney disease, after a fluorescein angiography. This is a before and after study that will include 35 patients from the department of ophtalmology over 6 months with a total follow-up for 3 months.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•\>18 years old with type 2 or type 1 diabetes and chronic kidney disease stage 3b to 5 (eGFR\<45 mL/min/1.73 m2)

Exclusion Criteria

•Patients who do not give their consent
•Patients who are allergic to fluorescein
•Patients who are on dialysis
•Patients who had fever, vomiting, diarrhea or any dehydration 48 hours before the intervention
•Patients who had a treatment modification one week before the intervention

Related studies

Active Not Recruiting

Evaluation of a Multidisciplinary Care Pathway on the Evolution of Renal Function in Patients With Advanced Chronic Kidney Disease

NCT06495385 · Chronic Kidney Disease stage4, Chronic Kidney Disease Stage 5

Not Yet RecruitingNA

Kidney Transplant Improvement Through New Exercise Training to Increase Capacity

NCT07446296 · Chronic Kidney Disease 5D, Chronic Kidney Disease Stage 5, and more

Controlling Hypertension Through Education and Coaching in Kidney Disease

NCT04087798 · Chronic Kidney Diseases, Chronic Disease, and more

A Pragmatic Approach to CKD Patient Education

NCT05138419 · Chronic Kidney Disease stage3, Chronic Kidney Disease stage4, and more

PR-0164 First in Human Clinical Trial of the PAVmed PortIO Intraosseous Infusion System

NCT06037265 · Chronic Kidney Disease stage3, Chronic Kidney Disease stage4, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 7, 2025Terms

Trial snapshot

StatusNOT_YET_RECRUITING

PhaseNA

Enrollment35

Start dateJan 2025

Last updatedJan 7, 2025

Condition

Chronic Kidney Disease Stage 4 Chronic Kidney Disease Stage 3B Chronic Kidney Disease Stage 5 Diabetes Mellitus Fluorescein Angiography+1 more

Locations shown

Faculty of Medicine, Saint Joseph University of Beirut

Beirut

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 7, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions